Clinical Utility of Capnography in the PACU( Post-anaesthesia Care Unit)
A Multi-Center Pilot Observational Trial to Quantify the Potential Clinical Utility of Capnography in the PACU
1 other identifier
observational
250
2 countries
2
Brief Summary
Multi-center observational trial with study device blinded in order to assess in parallel standard monitoring and intervention practices related to management of respiratory compromise in the post-anaesthesia care unit (PACU)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2016
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 7, 2016
CompletedFirst Posted
Study publicly available on registry
March 11, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2018
CompletedJuly 23, 2020
July 1, 2020
1.4 years
March 7, 2016
July 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of Respiratory Adverse Events in the PACU identified by capnography
Identification by blinded capnography to understand the ventilation challenges of patient in the PACU during standard of care that does not include capnography. First tier is RN (Registered Nurse) level of notification for early intervention and second tier is level at which covering MD (Medical Doctor) might request notification: 1. High Respiration Rate \>25 bpm for \> 15 seconds (tier one) and \>30 bpm for more than 30 seconds (tier two) 2. Low Respiration Rate \< 8 bpm for more than 15 seconds and \< 6 bpm for more than 30 seconds 3. High end tidal CO2 (EtCO2) \> 55 mmHg for \> 15 seconds and \> 60 mmHg for more than 30 seconds 4. Low EtCO2 \< 25 mmHg for \> 15 seconds and \< 25 mmHg for more than 30 seconds 5. High Heart Rate \> 120/min for 15 seconds and \>120/min for 30 seconds 6. Low Heart Rate \< 40/min for 15 seconds and \< 40/min for 30 seconds 7. SpO2 (oxygen saturation by pulse oximetry) /Hypoxemia \< 90% for more than 15 seconds and\< 90% for more than 30 seconds
Up to 2 hours in the PACU
Secondary Outcomes (2)
Frequency of Critical Adverse Events (CRAE)
PACU and 24 hours post PACU
Ventilation insufficiency on transfer from the PACU
At PACU discharge
Study Arms (2)
AZ PACU
Observation of standard of care with capnography blinded
TWH PACU
Observation of standard of care with capnography blinded
Eligibility Criteria
Adults booked for a surgical procedure that meet the I/E criteria and willing to provide consent for observation in the PACU and chart review 24 hours post PACU discharge.
You may qualify if:
- Adult ≥ 18 years of age
- ASA Score II - IV (American Society of Anaesthesiologists Score)
- Patients booked for a surgical procedure requiring general anesthesia care
- Expected duration of general anesthesia to be \> 1.5 hours
- Expected to receive intraoperative opioids
- Expected to be transferred to the PACU from the operating room
- Patients with an expected duration in the PACU ≥ 45 minutes
- Expected to be transferred from the PACU to an in-patient setting
You may not qualify if:
- Patients expected to be discharged from the hospital when discharged from the PACU
- Subjects who will have oral/nasal surgery that may prevent wearing an oral/nasal capnography sampling filterline.
- Subjects with a history of severe contact allergies that may cause a reaction to standard adhesive materials found in pulse oximetry sensors.
- Patients with skin lesions or physical deformities that would prevent the application of finger sensors for optimal performance.
- A female known to be pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medtronic - MITGlead
Study Sites (2)
Banner University Medical Center
Tucson, Arizona, 85724-5114, United States
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
Related Publications (2)
Kanaparthi A, Chung F, Lichtenthal PR, Sprung J, Weingarten TN. PRODIGY score predicts respiratory depression in the post-anesthesia care unit: A post-hoc analysis. Biomol Biomed. 2024 Oct 17;24(6):1662-1668. doi: 10.17305/bb.2024.10585.
PMID: 38843498DERIVEDChung F, Wong J, Mestek ML, Niebel KH, Lichtenthal P. Characterization of respiratory compromise and the potential clinical utility of capnography in the post-anesthesia care unit: a blinded observational trial. J Clin Monit Comput. 2020 Jun;34(3):541-551. doi: 10.1007/s10877-019-00333-9. Epub 2019 Jun 7.
PMID: 31175500DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter R Lichtenthal, MD
Banner University Medical Center
- PRINCIPAL INVESTIGATOR
Francis F Chung, MBBS FRCPC
University Health Network, Toronto
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2016
First Posted
March 11, 2016
Study Start
February 1, 2016
Primary Completion
June 15, 2017
Study Completion
June 15, 2018
Last Updated
July 23, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share